Tus kws kho mob
QP62-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Interleukin 5 (IL-5) Inhibitors
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2019
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2211 - 2220 ntawm 4374
Tus kws kho mob
QP60-19 2019 Blue Cross Basic Seminars
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2019
Tus kws kho mob
QP61-19 Availity Portal Authorization Frequently Asked Questions
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2019
Tus kws kho mob
QP63-19 When the Authorization Tool is Utilized on the Availity Portal
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 26, 2019
Tus kws kho mob
QP58-19 Pharmacy Benefit Exclusion for Zolgensma (onasemnogene abeparvovec-xioi) Injection
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP56-19 Pharmacy Benefit Update – New Drug-Related Step Therapy Criteria: Topical Corticosteroids
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP48-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Somatostatin Analogs
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP47-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP57-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization Criteria: tafamidis
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP49-19 Pharmacy Benefit Exclusion for Proventil (albuterol sulfate) HFA and Proventil (albuterol sulfate) HFA Authorized Generic (AG)
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019